Hanefeld, Markolf <br/><br/>
Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.  [electronic resource] 

 -  Diabetes, obesity & metabolism  11 2017 
 - 1594-1601 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12986  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Clinical Trials as Topic--statistics & numerical data<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Nephropathies--drug therapy<br/>Female<br/>Glomerular Filtration Rate<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptides--therapeutic use<br/>Renal Insufficiency--complications<br/>Severity of Illness Index<br/>Treatment Outcome